tiprankstipranks
Nova Mentis Life Science (NMLSF)
OTHER OTC:NMLSF

Nova Mentis Life Science (NMLSF) Stock Price & Analysis

17 Followers

NMLSF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $0.03
Previous Close$0.01
Volume340.00
Average Volume (3M)17.91K
Market Cap
$1.08M
Enterprise Value$1.06M
Total Cash (Recent Filing)C$21.82K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)
Beta-1.23
Aug 28, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding148,318,660
10 Day Avg. Volume9,439
30 Day Avg. Volume17,911
Standard Deviation0.38
R-Squared0.00001
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-3.66
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)2.90
P/FCF Ratio2.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Nova Mentis Life Science News

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

16.86%0.00%0.02%83.13%
16.86% Insiders
0.02% Other Institutional Investors
83.13% Public Companies and
Individual Investors

NMLSF FAQ

What was Nova Mentis Life Science’s price range in the past 12 months?
Nova Mentis Life Science lowest stock price was <$0.01 and its highest was $0.03 in the past 12 months.
    What is Nova Mentis Life Science’s market cap?
    Currently, no data Available
    When is Nova Mentis Life Science’s upcoming earnings report date?
    Nova Mentis Life Science’s upcoming earnings report date is Aug 28, 2024 which is in 36 days.
      How were Nova Mentis Life Science’s earnings last quarter?
      Currently, no data Available
      Is Nova Mentis Life Science overvalued?
      According to Wall Street analysts Nova Mentis Life Science’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Nova Mentis Life Science pay dividends?
        Nova Mentis Life Science does not currently pay dividends.
        What is Nova Mentis Life Science’s EPS estimate?
        Nova Mentis Life Science’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Nova Mentis Life Science have?
        Nova Mentis Life Science has 148,318,660 shares outstanding.
          What happened to Nova Mentis Life Science’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Nova Mentis Life Science?
          Currently, no hedge funds are holding shares in NMLSF
          ---

          Nova Mentis Life Science Stock Smart Score

          10
          Unlock Smart Score
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Negative
          20 days / 200 days
          Momentum
          -62.96%
          12-Months-Change

          Fundamentals

          Return on Equity
          Trailing 12-Months
          Asset Growth
          -82.51%
          Trailing 12-Months

          Company Description

          Nova Mentis Life Science

          Liberty Leaf Holdings Ltd. engages in building and supporting a diversified portfolio of cannabis-sector businesses. It offers cultivation, processing, value-added cannabidiol & pet products, and supply chain products. The company was founded on October 27, 2004 and is headquartered in Vancouver, Canada.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Palatin Technologies
          Acasti Pharma
          Can-Fite BioPharma
          HAVN Life Sciences
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis